Retatrutid, si nye atike yeye si wotu ɖe GLP-1 dzi, ƒoa GLP-1, GIP, kple glucagon receptor agonists nu ƒu tsɔ naa egbɔkpɔnu sẽŋu aɖe na lolo dzi ɖeɖe kpɔtɔ kple sukli si le ʋu me dzi ɖeɖe kpɔtɔ. Dɔdamɔnu dodokpɔwo ɖee fia be eɖea ame ƒe kpekpeme kple HbA1c ƒe agbɔsɔsɔ dzi kpɔtɔna ŋutɔ, si wɔe be wònye atike bubu si ŋugbe wodo na lolo akpa kple suklidɔ Ƒomevi 2 dada fifia. Togbɔ be zi geɖe la, eƒe nugbegblẽ le ame ŋu mesẽna o hã la, numekuku siwo le edzi yim ayi edzi anɔ eƒe dedienɔnɔ kple dɔwɔwɔ nyuie si anɔ anyi ɣeyiɣi didi la me dzrom. Retatrutid ƒe ŋutete gã aɖe le esi abe fefe-trɔla ene le lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe dɔlélewo dzi kpɔkpɔ me. Xlẽ Nu Geɖe

Retatrutid ƒoa GLP-1, GIP, kple glucagon receptor agonists nu ƒu tsɔ tɔa ŋku mɔ geɖe siwo kpɔa gome le kpekpeme dzi kpɔkpɔ kple ʋumesukli dzi ɖuɖu me. To insulin ƒe dɔwɔwɔ nyuie wu, nuɖuɖu ƒe dzodzro dzi ɖeɖe kpɔtɔ, kple ami ƒe asitɔtrɔ le lãme na ame me la, Retatrutid na lolo akpa kple suklidɔ Ƒomevi 2 ƒe egbɔkpɔnu blibo aɖe. Dɔdamɔnu dodokpɔ gbãtɔwo ɖee fia be ŋgɔyiyi gã aɖe va le lolo dzi ɖeɖe kpɔtɔ kple suklidɔ dzi ɖuɖu siaa me, si na Retatrutid ɖoe be enye atike yeye. Esi numekuku bubuwo kple dɔdamɔnu ŋuti nyatakakawo le dodom la, ŋutete le esi be wòatrɔ asi le lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe dɔlélewo dzi kpɔkpɔ ŋu. Xlẽ Nu Geɖe

Cocer Peptides nye dzɔdzɔme kpeɖeŋutɔ si naa lãmesẽmenɔnɔ ƒe viɖe geɖe, siwo dometɔ aɖewoe nye ŋusẽ ƒe agbɔsɔsɔ si nyona ɖe edzi, lãmekawo ɖɔɖɔɖo, ŋutigbalẽ ƒe lãmesẽ, kple susu ƒe dɔwɔwɔ. Peptide siawo wɔa dɔ to kpekpeɖeŋu nana ŋutilã ƒe dɔwɔwɔ vovovowo me, tso ami ƒe asitɔtrɔ dzi va ɖo dɔlélenutsiŋutete ƒe nyonyo dzi. Ne wotsɔe sɔ kple atike siwo wozãna tsã abe vitamin kple amino acid ene la, Cocer Peptides naa viɖe geɖe wu eye eƒe nugbegblẽ le ame ŋu mesɔ gbɔ o, si wɔe be wonye kpeɖeŋutɔ vevi aɖe na gbesiagbe lãmesẽmenɔnɔ ƒe ɖoɖo ɖesiaɖe. Xlẽ Nu Geɖe

GHK-Cu nye nusi wotsɔ tripeptide kple divalent copper ions wɔ. GHK-Cu le amegbetɔ ƒe ʋu, aɖuɖɔ, kple aɖuɖɔ me, eye eƒe agbɔsɔsɔ dzi ɖena kpɔtɔna vivivi ne ame tsi. Xlẽ Nu Geɖe

Tsitsi ƒe Lãmetsiŋusẽ (GH) wɔa akpa vevi aɖe le ŋutilã ƒe dɔwɔwɔ geɖe me, siwo dometɔ aɖewoe nye tsitsi, tsitsi, kple lãmenugbagbeviwo ƒe dɔwɔwɔ nyuie le nugbagbewo me. Xlẽ Nu Geɖe

Prostamax nye nusi do ƒome kple bioactive peptides si ɖee fia be ewɔa dɔ nyuie le prostatitis si me dɔlékui mele o si nɔa anyi didi kple nɔnɔme bubuwo dada me. Xlẽ Nu Geɖe

Mazdutide nye atike yeye aɖe si wɔa dɔ abe glucagon-like peptide-1 (GLP-1) kple glucagon xɔlawo ƒe dɔlékuiwutike eve ene. GLP-1 kple glucagon xɔlawo wɔa akpa vevi aɖe le lãmenugbagbeviwo ƒe dɔwɔwɔ dzi kpɔkpɔ le amegbetɔ ƒe ŋutilã me. Xlẽ Nu Geɖe

Le ƒe ʋɛ siwo va yi me la, esi numekuku siwo wowɔ tso lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe dɔlélewo ƒe dzɔdzɔ ŋu va le goglom ta la, atike siwo wozãna tsɔ daa dɔlékuiwutike geɖe siwo wozãna tsɔ tsia lãmetsiŋusẽ ƒe dɔlékuiwo ƒe dɔwɔwɔ nu geɖe la toto vɛ va zu nyati vevi aɖe. Retatrutid nye atike etɔ̃ yeye si tsia sukli si nɔa te ɖe insulinotropic polypeptide (GIP), sukli-si le abe peptide-1 (GLP-1), kple sukli (GC) xɔlawo dzi. Xlẽ Nu Geɖe

Sidzedze ƒe dɔmawɔmawɔ nyuie nye dɔlélewo ƒe ƒuƒoƒo aɖe si gblẽa nu le ahɔhɔ̃a ƒe susu ƒe dɔwɔwɔ ŋu, siwo dometɔ aɖewoe nye dzesiwo abe ŋkuɖoɖonudzi ƒe dɔmawɔmawɔ nyuie, susu ƒe dɔwɔwɔ sesẽ, kple tamebubu ŋutete ƒe ɖiɖi, siwo gblẽa nu le dɔnɔwo ƒe agbenɔnɔ ƒe nyonyome ŋu vevie. Xlẽ Nu Geɖe